Skip to content
2000
Volume 32, Issue 9
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

This review explores the critical role of mitochondria in the immunometabolic processes underlying rheumatoid arthritis (RA) and osteoarthritis (OA). It examines the interplay between immune cells, metabolic demands, and tissue environments, emphasizing the impact of bioenergetics on immune responses and disease progression. Mitochondrial dysfunction in chondrocytes and immune cells contributes to OA and RA through mechanisms such as oxidative stress, disrupted calcium homeostasis, and inflammasome activation. In OA, mitochondrial dysfunction in chondrocytes results in impaired energy production, elevated reactive oxygen species (ROS), and calcium imbalance, leading to cartilage degradation and inflammation. The review highlights how disturbances in the mitochondrial respiratory chain and apoptotic pathways drive joint tissue damage. In contrast, RA shows how mitochondrial dysfunction influences chronic inflammation and synovial hyperplasia. The role of mitochondrial DNA (mtDNA) as a damage-associated molecular pattern (DAMP) is emphasized, illustrating how oxidized mtDNA activates inflammatory pathways, triggers immune responses, and contributes to joint destruction. Additionally, mitochondrial genetic variations may exacerbate inflammation and oxidative stress in RA. The review also discusses the effects of various RA treatments-conventional synthetic anti-rheumatic drugs, biological agents, and targeted synthetic DMARDs-on mitochondrial function. Insights into how these therapies modulate mitochondrial pathways and oxidative stress in immune and joint cells highlight new potential treatment strategies. This review enhances our understanding of OA and RA pathophysiology by elucidating the connections between mitochondria, immune responses, and rheumatic diseases, paving the way for innovative therapies targeting mitochondrial dysfunction.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128354572250408165158
2025-04-30
2026-02-28

  • From This Site

    /content/journals/cpd/10.2174/0113816128354572250408165158
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GaneshanK. ChawlaA. Metabolic regulation of immune responses.Annu. Rev. Immunol.201432160963410.1146/annurev‑immunol‑032713‑12023624655299
     [Google Scholar]
  2. ChenS. SaeedA.F.U.H. LiuQ. JiangQ. XuH. XiaoG.G. RaoL. DuoY. Macrophages in immunoregulation and therapeutics.Signal Transduct. Target. Ther.20238120710.1038/s41392‑023‑01452‑137211559
     [Google Scholar]
  3. AristizábalB. GonzálezÁ. Innate immune system.Autoimmunity: From Bench to Bedside. AnayaJ.M. ShoenfeldY. Rojas-VillarragaA. Bogota, ColombiaEl Rosario University Press2013
     [Google Scholar]
  4. MorrisA.L. MohiuddinS.S. Biochemistry, nutrients.StatPearls.Treasure Island, FLStatPearls Publishing2024
     [Google Scholar]
  5. RademakersT. HorvathJ.M. BlitterswijkC.A. LaPointeV.L.S. Oxygen and nutrient delivery in tissue engineering: Approaches to graft vascularization.J. Tissue Eng. Regen. Med.201913101815182910.1002/term.293231310055
     [Google Scholar]
  6. GarciaC. AndersenC.J. BlessoC.N. The role of lipids in the regulation of immune responses.Nutrients20231518389910.3390/nu1518389937764683
     [Google Scholar]
  7. WangS. JungS. KoK.S. Effects of amino acids supplementation on lipid and glucose metabolism in HepG2 cells.Nutrients20221415305010.3390/nu1415305035893906
     [Google Scholar]
  8. ZengQ. SunX. XiaoL. XieZ. BettiniM. DengT. A unique population: Adipose-resident regulatory T cells.Front. Immunol.20189207510.3389/fimmu.2018.0207530323806
     [Google Scholar]
  9. AbdulkhaleqL.A. AssiM.A. AbdullahR. Zamri-SaadM. Taufiq-YapY.H. HezmeeM.N.M. The crucial roles of inflammatory mediators in inflammation: A review.Vet. World201811562763510.14202/vetworld.2018.627‑63529915501
     [Google Scholar]
  10. NeogiT. The epidemiology and impact of pain in osteoarthritis.Osteoarthritis Cartilage20132191145115310.1016/j.joca.2013.03.01823973124
     [Google Scholar]
  11. Di NicolaV. Degenerative osteoarthritis a reversible chronic disease.Regen. Ther.20201514916010.1016/j.reth.2020.07.00733426213
     [Google Scholar]
  12. YaoQ. WuX. TaoC. GongW. ChenM. QuM. ZhongY. HeT. ChenS. XiaoG. Osteoarthritis: Pathogenic signaling pathways and therapeutic targets.Signal Transduct. Target. Ther.2023815610.1038/s41392‑023‑01330‑w36737426
     [Google Scholar]
  13. QiZ. ZhuJ. CaiW. LouC. LiZ. The role and intervention of mitochondrial metabolism in osteoarthritis.Mol. Cell. Biochem.202447961513152410.1007/s11010‑023‑04818‑937486450
     [Google Scholar]
  14. De NicoloB. Cataldi-StagettiE. DiquigiovanniC. BonoraE. Calcium and reactive oxygen species signaling interplays in cardiac physiology and pathologies.Antioxidants202312235310.3390/antiox1202035336829912
     [Google Scholar]
  15. ZiskovenC. JägerM. ZilkensC. BlochW. BrixiusK. KrauspeR. Oxidative stress in secondary osteoarthritis: From cartilage destruction to clinical presentation?Orthop. Rev. (Pavia)201022e2310.4081/or.2010.e2321808712
     [Google Scholar]
  16. PrimoracD. MolnarV. RodE. JelečŽ. ČukeljF. MatišićV. VrdoljakT. HudetzD. HajsokH. BorićI. Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations.Genes202011885410.3390/genes1108085432722615
     [Google Scholar]
  17. DoveA.P.H. CmelakA. DarrowK. McComasK.N. ChowdharyM. BecktaJ. KirschnerA.N. The use of low-dose radiation therapy in osteoarthritis: A review.Int. J. Radiat. Oncol. Biol. Phys.2022114220322010.1016/j.ijrobp.2022.04.02935504501
     [Google Scholar]
  18. YasmeenF. PirzadaR.H. AhmadB. ChoiB. ChoiS. Understanding autoimmunity: Mechanisms, predisposing factors, and cytokine therapies.Int. J. Mol. Sci.20242514766610.3390/ijms2514766639062908
     [Google Scholar]
  19. LoeserR.F. GoldringS.R. ScanzelloC.R. GoldringM.B. Osteoarthritis: A disease of the joint as an organ.Arthritis Rheum.20126461697170710.1002/art.3445322392533
     [Google Scholar]
  20. CoaccioliS. Sarzi-PuttiniP. ZisP. RinonapoliG. VarrassiG. Osteoarthritis: New insight on its pathophysiology.J. Clin. Med.20221120601310.3390/jcm1120601336294334
     [Google Scholar]
  21. HsuW.C. AranetaM.R.G. KanayaA.M. ChiangJ.L. FujimotoW. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening.Diabetes Care201538115015810.2337/dc14‑239125538311
     [Google Scholar]
  22. Dalmao-FernándezA. Hermida-GómezT. Nogueira-RecaldeU. Rego-PérezI. Blanco-GarciaF.J. Fernández-MorenoM. Mitochondrial role on cellular apoptosis, autophagy, and senescence during osteoarthritis pathogenesis.Cells2024131197610.3390/cells1311097638891108
     [Google Scholar]
  23. LiuH.Y. ChangC.F. LuC.C. WuS.C. HuangB. ChengT.L. LinS.Y. HoC.J. LeeM.J. YangC.D. WangY.C. LiJ.Y. LiuP.C. WeiC.W. KangL. ChenC.H. The role of mitochondrial metabolism, AMPK-SIRT mediated pathway, LncRNA and MicroRNA in osteoarthritis.Biomedicines2022107147710.3390/biomedicines1007147735884782
     [Google Scholar]
  24. BlancoF.J. López-ArmadaM.J. ManeiroE. Mitochondrial dysfunction in osteoarthritis.Mitochondrion200445-671572810.1016/j.mito.2004.07.02216120427
     [Google Scholar]
  25. AdamM.S. ZhuangH. RenX. ZhangY. ZhouP. The metabolic characteristics and changes of chondrocytes in vivo and in vitro in osteoarthritis.Front. Endocrinol. (Lausanne)202415139355010.3389/fendo.2024.139355038854686
     [Google Scholar]
  26. JinK. QianC. LinJ. LiuB. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells.Front. Oncol.202313109981110.3389/fonc.2023.109981136776289
     [Google Scholar]
  27. Redza-DutordoirM. Averill-BatesD.A. Activation of apoptosis signalling pathways by reactive oxygen species.Biochim. Biophys. Acta Mol. Cell Res.20161863122977299210.1016/j.bbamcr.2016.09.01227646922
     [Google Scholar]
  28. NissankaN. MoraesC.T. Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease.FEBS Lett.2018592572874210.1002/1873‑3468.1295629281123
     [Google Scholar]
  29. LiuL. LuoP. YangM. WangJ. HouW. XuP. The role of oxidative stress in the development of knee osteoarthritis: A comprehensive research review.Front. Mol. Biosci.20229100121210.3389/fmolb.2022.100121236203877
     [Google Scholar]
  30. NitaM. GrzybowskiA. The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults.Oxid. Med. Cell. Longev.201620161316473410.1155/2016/316473426881021
     [Google Scholar]
  31. ZhangD. WangF. LiP. GaoY. Mitochondrial Ca2+ homeostasis: Emerging roles and clinical significance in cardiac remodeling.Int. J. Mol. Sci.2022236302510.3390/ijms2306302535328444
     [Google Scholar]
  32. PandaS. BeheraS. AlamM.F. SyedG.H. Endoplasmic reticulum & mitochondrial calcium homeostasis: The interplay with viruses.Mitochondrion20215822724210.1016/j.mito.2021.03.00833775873
     [Google Scholar]
  33. Vaamonde-GarcíaC. Riveiro-NaveiraR.R. Valcárcel-AresM.N. Hermida-CarballoL. BlancoF.J. López-ArmadaM.J. Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes.Arthritis Rheum.20126492927293610.1002/art.3450822549761
     [Google Scholar]
  34. MuraokaN. NaraK. TamuraF. KojimaH. YamakawaH. SadahiroT. MiyamotoK. IsomiM. HaginiwaS. TaniH. KurotsuS. OsakabeR. ToriiS. ShimizuS. OkanoH. SugimotoY. FukudaK. IedaM. Role of cyclooxygenase-2- mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming.Nat. Commun.201910167410.1038/s41467‑019‑08626‑y30787297
     [Google Scholar]
  35. HwangH. KimH. Chondrocyte apoptosis in the pathogenesis of osteoarthritis.Int. J. Mol. Sci.20151611260352605410.3390/ijms16112594326528972
     [Google Scholar]
  36. WangR. MaimaitijumaT. MaY.Y. JiaoY. CaoY.P. Mitochondrial transfer from bone-marrow-derived mesenchymal stromal cells to chondrocytes protects against cartilage degenerative mitochondrial dysfunction in rats chondrocytes.Chin. Med. J. (Engl.)2021134221221810.1097/CM9.000000000000105732858593
     [Google Scholar]
  37. WangC. YouleR.J. The role of mitochondria in apoptosis.Annu. Rev. Genet.20094319511810.1146/annurev‑genet‑102108‑13485019659442
     [Google Scholar]
  38. LiY. RasheedM. LiuJ. ChenZ. DengY. Deciphering the molecular nexus: An in-depth review of mitochondrial pathways and their role in cell death crosstalk.Cells2024131086310.3390/cells1310086338786088
     [Google Scholar]
  39. MustafaM. AhmadR. TantryI.Q. AhmadW. SiddiquiS. AlamM. AbbasK. Moinuddin HassanM.I. HabibS. IslamS. Apoptosis: A comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications.Cells20241322183810.3390/cells1322183839594587
     [Google Scholar]
  40. HoffmannR.F. JonkerM.R. BrandenburgS.M. de BruinH.G. ten HackenN.H.T. van OosterhoutA.J.M. HeijinkI.H. Mitochondrial dysfunction increases pro-inflammatory cytokine production and impairs repair and corticosteroid responsiveness in lung epithelium.Sci. Rep.2019911504710.1038/s41598‑019‑51517‑x31636329
     [Google Scholar]
  41. KaoW.C. ChenJ.C. LiuP.C. LuC.C. LinS.Y. ChuangS.C. WuS.C. ChangL. LeeM.J. YangC.D. LeeT.C. WangY.C. LiJ.Y. WeiC.W. ChenC.H. The role of autophagy in osteoarthritic cartilage.Biomolecules20221210135710.3390/biom1210135736291565
     [Google Scholar]
  42. GetoZ. MollaM.D. ChallaF. BelayY. GetahunT. Mitochondrial dynamic dysfunction as a main triggering factor for inflammation associated chronic non-communicable diseases.J. Inflamm. Res.2020139710710.2147/JIR.S23200932110085
     [Google Scholar]
  43. Amador-MartínezI. Aparicio-TrejoO.E. Bernabe-YepesB. Aranda-RiveraA.K. Cruz-GregorioA. Sánchez-LozadaL.G. Pedraza-ChaverriJ. TapiaE. Mitochondrial impairment: A link for inflammatory responses activation in the cardiorenal syndrome type 4.Int. J. Mol. Sci.202324211587510.3390/ijms24211587537958859
     [Google Scholar]
  44. GrässelS. ZauckeF. MadryH. Osteoarthritis: Novel molecular mechanisms increase our understanding of the disease pathology.J. Clin. Med.2021109193810.3390/jcm1009193833946429
     [Google Scholar]
  45. ChenC. XieJ. RajappaR. DengL. FredbergJ. YangL. Interleukin-1β and tumor necrosis factor-α increase stiffness and impair contractile function of articular chondrocytes.Acta Biochim. Biophys. Sin. (Shanghai)201547212112910.1093/abbs/gmu11625520178
     [Google Scholar]
  46. HorváthE. SólyomÁ. SzékelyJ. NagyE.E. PopoviciuH. Inflammatory and metabolic signaling interfaces of the hypertrophic and senescent chondrocyte phenotypes associated with osteoarthritis.Int. J. Mol. Sci.202324221646810.3390/ijms24221646838003658
     [Google Scholar]
  47. Cabral-PachecoG.A. Garza-VelozI. Castruita-De la RosaC. Ramirez-AcuñaJ.M. Perez-RomeroB.A. Guerrero-RodriguezJ.F. Martinez-AvilaN. Martinez-FierroM.L. The roles of matrix metalloproteinases and their inhibitors in human diseases.Int. J. Mol. Sci.20202124973910.3390/ijms2124973933419373
     [Google Scholar]
  48. YoungD.A. BarterM.J. WilkinsonD.J. Recent advances in understanding the regulation of metalloproteinases. F1000Research, 8, F1000 Faculty Rev-195.F1000Research2019810.12688/f1000research.17471.1
     [Google Scholar]
  49. GuanM. YuQ. ZhouG. WangY. YuJ. YangW. LiZ. Mechanisms of chondrocyte cell death in osteoarthritis: Implications for disease progression and treatment.J. Orthop. Surg. Res.202419155010.1186/s13018‑024‑05055‑639252111
     [Google Scholar]
  50. HanZ. WangK. DingS. ZhangM. Cross-talk of inflammation and cellular senescence: A new insight into the occurrence and progression of osteoarthritis.Bone Res.20241216910.1038/s41413‑024‑00375‑z39627227
     [Google Scholar]
  51. KanS. DuanM. LiuY. WangC. XieJ. Role of mitochondria in physiology of chondrocytes and diseases of osteoarthritis and rheumatoid arthritis.Cartilage2021132_suppl1102S1121S10.1177/1947603521106385834894777
     [Google Scholar]
  52. ZhaoT. NiuD. ChenY. FuP. The role of mitochondrial quality control mechanisms in chondrocyte senescence.Exp. Gerontol.202418811237910.1016/j.exger.2024.11237938378048
     [Google Scholar]
  53. PiP. ZengL. ZengZ. ZongK. HanB. BaiX. WangY. The role of targeting glucose metabolism in chondrocytes in the pathogenesis and therapeutic mechanisms of osteoarthritis: a narrative review.Front. Endocrinol. (Lausanne)202415131982710.3389/fendo.2024.131982738510704
     [Google Scholar]
  54. KowalczykP. SulejczakD. KleczkowskaP. Bukowska-OśkoI. KuciaM. PopielM. WietrakE. KramkowskiK. WrzosekK. KaczyńskaK. Mitochondrial oxidative stress: A causative factor and therapeutic target in many diseases.Int. J. Mol. Sci.202122241338410.3390/ijms22241338434948180
     [Google Scholar]
  55. MaoX. FuP. WangL. XiangC. Mitochondria: Potential targets for osteoarthritis.Front. Med. (Lausanne)2020758140210.3389/fmed.2020.58140233324661
     [Google Scholar]
  56. SchefferD.L. GarciaA.A. LeeL. Mochly-RosenD. FerreiraJ.C.B. Mitochondrial fusion, fission, and mitophagy in cardiac diseases: Challenges and therapeutic opportunities.Antioxid. Redox Signal.20223613-1584486310.1089/ars.2021.014535044229
     [Google Scholar]
  57. RenL. ChenX. ChenX. LiJ. ChengB. XiaJ. Mitochondrial dynamics: Fission and fusion in fate determination of mesenchymal stem cells.Front. Cell Dev. Biol.2020858007010.3389/fcell.2020.58007033178694
     [Google Scholar]
  58. WangS. TanJ. MiaoY. ZhangQ. Mitochondrial dynamics, mitophagy, and mitochondria–endoplasmic reticulum contact sites crosstalk under hypoxia.Front. Cell Dev. Biol.20221084821410.3389/fcell.2022.84821435281107
     [Google Scholar]
  59. ZhengL. ZhangZ. ShengP. MobasheriA. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis.Ageing Res. Rev.20216610124910.1016/j.arr.2020.10124933383189
     [Google Scholar]
  60. SongY. ZhouY. ZhouX. The role of mitophagy in innate immune responses triggered by mitochondrial stress.Cell Commun. Signal.202018118610.1186/s12964‑020‑00659‑x33239048
     [Google Scholar]
  61. DefoisA. BonN. CharpentierA. GeorgetM. GaigeardN. BlanchardF. HamelA. WaastD. ArmengaudJ. RenoultO. PecqueurC. MaugarsY. BoutetM.A. GuicheuxJ. VinatierC. Osteoarthritic chondrocytes undergo a glycolysis-related metabolic switch upon exposure to IL-1b or TNF.Cell Commun. Signal.202321113710.1186/s12964‑023‑01150‑z37316888
     [Google Scholar]
  62. KühnK. D’LimaD.D. HashimotoS. LotzM. Cell death in cartilage.Osteoarthritis Cartilage200412111610.1016/j.joca.2003.09.01514697678
     [Google Scholar]
  63. BaumgartnerH.K. GerasimenkoJ.V. ThorneC. FerdekP. PozzanT. TepikinA.V. PetersenO.H. SuttonR. WatsonA.J.M. GerasimenkoO.V. Calcium elevation in mitochondria is the main Ca2+ requirement for mitochondrial permeability transition pore (mPTP) opening.J. Biol. Chem.200928431207962080310.1074/jbc.M109.02535319515844
     [Google Scholar]
  64. BaevA.Y. VinokurovA.Y. NovikovaI.N. DreminV.V. PotapovaE.V. AbramovA.Y. Interaction of mitochondrial calcium and ROS in neurodegeneration.Cells202211470610.3390/cells1104070635203354
     [Google Scholar]
  65. HeY. WuZ. XuL. XuK. ChenZ. RanJ. WuL. The role of SIRT3-mediated mitochondrial homeostasis in osteoarthritis.Cell. Mol. Life Sci.202077193729374310.1007/s00018‑020‑03497‑932468094
     [Google Scholar]
  66. ZhangM. WuJ. CaiK. LiuY. LuB. ZhangJ. XuJ. GuC. ChenT. From dysfunction to healing: Advances in mitochondrial therapy for Osteoarthritis.J. Transl. Med.2024221101310.1186/s12967‑024‑05799‑z39529128
     [Google Scholar]
  67. LeeK.H. KimU.J. LeeB.H. ChaM. Safeguarding the brain from oxidative damage.Free Radic. Biol. Med.2025226143157Epub ahead of print10.1016/j.freeradbiomed.2024.11.01939547523
     [Google Scholar]
  68. TumilaarS.G. HardiantoA. DohiH. KurniaD. A comprehensive review of free radicals, oxidative stress, and antioxidants: Overview, clinical applications, global perspectives, future directions, and mechanisms of antioxidant activity of flavonoid compounds.J. Chem.2024202412110.1155/2024/5594386
     [Google Scholar]
  69. WangH. SuJ. YuM. XiaY. WeiY. PGC-1α in osteoarthritic chondrocytes: From mechanism to target of action.Front. Pharmacol.202314116901910.3389/fphar.2023.116901937089944
     [Google Scholar]
  70. Abu ShelbayehO. ArroumT. MorrisS. BuschK.B. PGC-1α is a master regulator of mitochondrial lifecycle and ros stress response.Antioxidants2023125107510.3390/antiox1205107537237941
     [Google Scholar]
  71. LinZ. WangH. SongJ. XuG. LuF. MaX. XiaX. JiangJ. ZouF. The role of mitochondrial fission in intervertebral disc degeneration.Osteoarthritis Cartilage202331215816610.1016/j.joca.2022.10.02036375758
     [Google Scholar]
  72. ZhouQ. RenC. LiJ. WangL. DuanY. YaoR. TianY. YaoY. The crosstalk between mitochondrial quality control and metal-dependent cell death.Cell Death Dis.202415429910.1038/s41419‑024‑06691‑w38678018
     [Google Scholar]
  73. ZhuX. QinZ. ZhouM. LiC. JingJ. YeW. GanX. The role of mitochondrial permeability transition in bone metabolism, bone healing, and bone diseases.Biomolecules20241410131810.3390/biom1410131839456250
     [Google Scholar]
  74. AgarwalA. WuP.H. HughesE.G. FukayaM. TischfieldM.A. LangsethA.J. WirtzD. BerglesD.E. Transient opening of the mitochondrial permeability transition pore induces microdomain calcium transients in astrocyte processes.Neuron2017933587605.e710.1016/j.neuron.2016.12.03428132831
     [Google Scholar]
  75. Clemente-SuárezV.J. Martín-RodríguezA. Yáñez-SepúlvedaR. Tornero-AguileraJ.F. Mitochondrial transfer as a novel therapeutic approach in disease diagnosis and treatment.Int. J. Mol. Sci.20232410884810.3390/ijms2410884837240194
     [Google Scholar]
  76. BourebabaL. BourebabaN. GaluppoL. MaryczK. Artificial mitochondrial transplantation (AMT) reverses aging of mesenchymal stromal cells and improves their immunomodulatory properties in LPS-induced synoviocytes inflammation.Biochim. Biophys. Acta Mol. Cell Res.20241871711980610.1016/j.bbamcr.2024.11980639098401
     [Google Scholar]
  77. VelardeF. EzquerraS. DelbruyereX. CaicedoA. HidalgoY. KhouryM. Mesenchymal stem cell-mediated transfer of mitochondria: Mechanisms and functional impact.Cell. Mol. Life Sci.202279317710.1007/s00018‑022‑04207‑335247083
     [Google Scholar]
  78. LiuQ. ZhangX. ZhuT. XuZ. DongY. ChenB. Mitochondrial transfer from mesenchymal stem cells: Mechanisms and functions.Mitochondrion20247910195010.1016/j.mito.2024.10195039218052
     [Google Scholar]
  79. MalekpourK. HazratiA. SoudiS. HashemiS.M. Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery.J. Control. Release202335475576910.1016/j.jconrel.2023.01.05936706838
     [Google Scholar]
  80. Di MambroT. PellieloG. AgyapongE.D. CarinciM. ChianeseD. GiorgiC. MorcianoG. PatergnaniS. PintonP. RimessiA. The tricky connection between extracellular vesicles and mitochondria in inflammatory-related diseases.Int. J. Mol. Sci.2023249818110.3390/ijms2409818137175888
     [Google Scholar]
  81. PayandehZ. TangruksaB. SynnergrenJ. Heydarkhan-HagvallS. NordinJ.Z. AndaloussiS.E.L. BorénJ. WisemanJ. Bohlooly-YM. LindforsL. ValadiH. Extracellular vesicles transport RNA between cells: Unraveling their dual role in diagnostics and therapeutics.Mol. Aspects Med.20249910130210.1016/j.mam.2024.10130239094449
     [Google Scholar]
  82. LiJ. WangT. HouX. LiY. ZhangJ. BaiW. QianH. SunZ. Extracellular vesicles: Opening up a new perspective for the diagnosis and treatment of mitochondrial dysfunction.J. Nanobiotechnology202422148710.1186/s12951‑024‑02750‑839143493
     [Google Scholar]
  83. GuoQ. WangY. XuD. NossentJ. PavlosN.J. XuJ. Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies.Bone Res.2018611510.1038/s41413‑018‑0016‑929736302
     [Google Scholar]
  84. ChecaJ. AranJ.M. Reactive oxygen species: Drivers of physiological and pathological processes.J. Inflamm. Res.2020131057107310.2147/JIR.S27559533293849
     [Google Scholar]
  85. FockE.M. ParnovaR.G. Protective effect of mitochondria-targeted antioxidants against inflammatory response to lipopolysaccharide challenge: A review.Pharmaceutics202113214410.3390/pharmaceutics1302014433499252
     [Google Scholar]
  86. PatergnaniS. BouhamidaE. LeoS. PintonP. RimessiA. Mitochondrial oxidative stress and “Mito-Inflammation”: Actors in the diseases.Biomedicines20219221610.3390/biomedicines902021633672477
     [Google Scholar]
  87. BolducJ.A. CollinsJ.A. LoeserR.F. Reactive oxygen species, aging and articular cartilage homeostasis.Free Radic. Biol. Med.2019132738210.1016/j.freeradbiomed.2018.08.03830176344
     [Google Scholar]
  88. BerdiakiA. NeaguM. SpyridakiI. KuskovA. PerezS. NikitovicD. Hyaluronan and reactive oxygen species signaling: Novel cues from the matrix?Antioxidants202312482410.3390/antiox1204082437107200
     [Google Scholar]
  89. MaC. WangJ. HongF. YangS. Mitochondrial dysfunction in rheumatoid arthritis.Biomolecules2022129121610.3390/biom1209121636139055
     [Google Scholar]
  90. AnsariM.Y. KhanN.M. AhmadI. HaqqiT.M. Parkin clearance of dysfunctional mitochondria regulates ROS levels and increases survival of human chondrocytes.Osteoarthritis Cartilage20182681087109710.1016/j.joca.2017.07.02028801211
     [Google Scholar]
  91. KronzerV.L. SparksJ.A. RaychaudhuriS. CerhanJ.R. Low-frequency and rare genetic variants associated with rheumatoid arthritis risk.Nat. Rev. Rheumatol.202420529030010.1038/s41584‑024‑01096‑738538758
     [Google Scholar]
  92. RiitanoG. RecalchiS. CapozziA. ManganelliV. MisasiR. GarofaloT. SoriceM. LongoA. The role of autophagy as a trigger of post-translational modifications of proteins and extracellular vesicles in the pathogenesis of rheumatoid arthritis.Int. J. Mol. Sci.202324161276410.3390/ijms24161276437628944
     [Google Scholar]
  93. Matuz-MaresD. González-AndradeM. Araiza-VillanuevaM.G. Vilchis-LanderosM.M. Vázquez-MezaH. Mitochondrial calcium: Effects of its imbalance in disease.Antioxidants202211580110.3390/antiox1105080135624667
     [Google Scholar]
  94. MoonD.O. Calcium’s role in orchestrating cancer apoptosis: Mitochondrial-centric perspective.Int. J. Mol. Sci.20232410898210.3390/ijms2410898237240331
     [Google Scholar]
  95. WeyandC.M. WuB. HuangT. HuZ. GoronzyJ.J. Mitochondria as disease-relevant organelles in rheumatoid arthritis.Clin. Exp. Immunol.2023211320822310.1093/cei/uxac10736420636
     [Google Scholar]
  96. MittalM. SiddiquiM.R. TranK. ReddyS.P. MalikA.B. Reactive oxygen species in inflammation and tissue injury.Antioxid. Redox Signal.20142071126116710.1089/ars.2012.514923991888
     [Google Scholar]
  97. ClaytonS.A. MacDonaldL. Kurowska-StolarskaM. ClarkA.R. Mitochondria as key players in the pathogenesis and treatment of rheumatoid arthritis.Front. Immunol.20211267391610.3389/fimmu.2021.67391633995417
     [Google Scholar]
  98. DiogoD. KurreemanF. StahlE.A. LiaoK.P. GuptaN. GreenbergJ.D. RivasM.A. HickeyB. FlannickJ. ThomsonB. GuiducciC. RipkeS. AdzhubeyI. BartonA. KremerJ.M. AlfredssonL. SunyaevS. MartinJ. ZhernakovaA. BowesJ. EyreS. SiminovitchK.A. GregersenP.K. WorthingtonJ. KlareskogL. PadyukovL. RaychaudhuriS. PlengeR.M. Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis.Am. J. Hum. Genet.2013921152710.1016/j.ajhg.2012.11.01223261300
     [Google Scholar]
  99. HuZ. LiY. ZhangL. JiangY. LongC. YangQ. YangM. Metabolic changes in fibroblast-like synoviocytes in rheumatoid arthritis: State of the art review.Front. Immunol.202415125088410.3389/fimmu.2024.125088438482018
     [Google Scholar]
  100. PromilaL. JoshiA. KhanS. AggarwalA. LahiriA. Role of mitochondrial dysfunction in the pathogenesis of rheumatoid arthritis: Looking closely at fibroblast- like synoviocytes.Mitochondrion202373627110.1016/j.mito.2023.10.00438506094
     [Google Scholar]
  101. ReunanenN. KähäriV.M. Matrix metalloproteinases in cancer cell invasion.Madame Curie Bioscience Database.Austin, TXLandes Bioscience2013
     [Google Scholar]
  102. López-ArmadaM.J. Fernández-RodríguezJ.A. BlancoF.J. Mitochondrial dysfunction and oxidative stress in rheumatoid arthritis.Antioxidants2022116115110.3390/antiox1106115135740048
     [Google Scholar]
  103. MoodleyD. ModyG. PatelN. ChuturgoonA.A. Mitochondrial depolarisation and oxidative stress in rheumatoid arthritis patients.Clin. Biochem.20084116-171396140110.1016/j.clinbiochem.2008.08.07218789914
     [Google Scholar]
  104. LaneR.S. FuY. MatsuzakiS. KinterM. HumphriesK.M. GriffinT.M. Mitochondrial respiration and redox coupling in articular chondrocytes.Arthritis Res. Ther.20151715410.1186/s13075‑015‑0566‑925889867
     [Google Scholar]
  105. WuX. LiyanageC. PlanM. StarkT. McCubbinT. BarreroR.A. BatraJ. CrawfordR. XiaoY. PrasadamI. Dysregulated energy metabolism impairs chondrocyte function in osteoarthritis.Osteoarthritis Cartilage202331561362610.1016/j.joca.2022.11.00436410637
     [Google Scholar]
  106. Dan DunnJ. AlvarezL.A.J. ZhangX. SoldatiT. Reactive oxygen species and mitochondria: A nexus of cellular homeostasis.Redox Biol.2015647248510.1016/j.redox.2015.09.00526432659
     [Google Scholar]
  107. TirichenH. YaigoubH. XuW. WuC. LiR. LiY. Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress.Front. Physiol.20211262783710.3389/fphys.2021.62783733967820
     [Google Scholar]
  108. FooJ. BellotG. PervaizS. AlonsoS. Mitochondria-mediated oxidative stress during viral infection.Trends Microbiol.202230767969210.1016/j.tim.2021.12.01135063304
     [Google Scholar]
  109. NakahiraK. HisataS. ChoiA.M.K. The roles of mitochondrial damage associated molecular patterns in diseases.Antioxid. Redox Signal.201523171329135010.1089/ars.2015.640726067258
     [Google Scholar]
  110. ChenS. LiaoZ. XuP. Mitochondrial control of innate immune responses.Front. Immunol.202314116621410.3389/fimmu.2023.116621437325622
     [Google Scholar]
  111. BoguszewskaK. SzewczukM. Kaźmierczak-BarańskaJ. KarwowskiB.T. The similarities between human mitochondria and bacteria in the context of structure, genome, and base excision repair system.Molecules20202512285710.3390/molecules2512285732575813
     [Google Scholar]
  112. RileyJ.S. TaitS.W.G. Mitochondrial DNA in inflammation and immunity.EMBO Rep.2020214e4979910.15252/embr.20194979932202065
     [Google Scholar]
  113. RossmannM.P. DuboisS.M. AgarwalS. ZonL.I. Mitochondrial function in development and disease.Dis. Model. Mech.2021146dmm04891210.1242/dmm.04891234114603
     [Google Scholar]
  114. JiaoY. YanZ. YangA. Mitochondria in innate immunity signaling and its therapeutic implications in autoimmune diseases.Front. Immunol.202314116003510.3389/fimmu.2023.116003537122709
     [Google Scholar]
  115. CadetJ. DaviesK.J.A. Oxidative DNA damage & repair: An introduction.Free Radic. Biol. Med.201710721210.1016/j.freeradbiomed.2017.03.03028363603
     [Google Scholar]
  116. LehmannJ. GiaglisS. KyburzD. DaoudlarianD. WalkerU.A. Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis.Arthritis Res. Ther.20242619710.1186/s13075‑024‑03329‑238715082
     [Google Scholar]
  117. RykovaE. SizikovA. RoggenbuckD. AntonenkoO. BryzgalovL. MorozkinE. SkvortsovaK. VlassovV. LaktionovP. KozlovV. Circulating DNA in rheumatoid arthritis: Pathological changes and association with clinically used serological markers.Arthritis Res. Ther.20171918510.1186/s13075‑017‑1295‑z28464939
     [Google Scholar]
  118. BoyapatiR.K. TamborskaA. DorwardD.A. HoG.T. Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases.F1000 Res.2017616910.12688/f1000research.10397.128299196
     [Google Scholar]
  119. PaleologE.M. The vasculature in rheumatoid arthritis: Cause or consequence?Int. J. Exp. Pathol.200990324926110.1111/j.1365‑2613.2009.00640.x19563609
     [Google Scholar]
  120. NgC.T. BinieckaM. KennedyA. McCormickJ. FitzGeraldO. BresnihanB. BuggyD. TaylorC.T. O’SullivanJ. FearonU. VealeD.J. Synovial tissue hypoxia and inflammation in vivo.Ann. Rheum. Dis.20106971389139510.1136/ard.2009.11977620439288
     [Google Scholar]
  121. Fresneda AlarconM. McLarenZ. WrightH.L. Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: Same foe different M.O.Front. Immunol.20211264969310.3389/fimmu.2021.64969333746988
     [Google Scholar]
  122. MandaA. PruchniakM.P. AraźnaM. DemkowU.A. Neutrophil extracellular traps in physiology and pathology.Cent. Eur. J. Immunol.20141111612110.5114/ceji.2014.4213626155111
     [Google Scholar]
  123. CaoZ. ZhaoM. SunH. HuL. ChenY. FanZ. Roles of mitochondria in neutrophils.Front. Immunol.20221393444410.3389/fimmu.2022.93444436081497
     [Google Scholar]
  124. LoodC. BlancoL.P. PurmalekM.M. Carmona-RiveraC. De RavinS.S. SmithC.K. MalechH.L. LedbetterJ.A. ElkonK.B. KaplanM.J. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.Nat. Med.201622214615310.1038/nm.402726779811
     [Google Scholar]
  125. WangM. IshikawaT. LaiY. NallapothulaD. SinghR.R. Diverse roles of NETosis in the pathogenesis of lupus.Front. Immunol.20221389521610.3389/fimmu.2022.89521635686129
     [Google Scholar]
  126. KimJ. KimH.S. ChungJ.H. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway.Exp. Mol. Med.202355351051910.1038/s12276‑023‑00965‑736964253
     [Google Scholar]
  127. ZhiyuW. WangN. WangQ. PengC. ZhangJ. LiuP. OuA. ZhongS. CorderoM.D. LinY. The inflammasome: An emerging therapeutic oncotarget for cancer prevention.Oncotarget2016731507665078010.18632/oncotarget.939127206676
     [Google Scholar]
  128. MarchiS. GuilbaudE. TaitS.W.G. YamazakiT. GalluzziL. Mitochondrial control of inflammation.Nat. Rev. Immunol.202323315917310.1038/s41577‑022‑00760‑x35879417
     [Google Scholar]
  129. ShimadaK. CrotherT.R. KarlinJ. DagvadorjJ. ChibaN. ChenS. RamanujanV.K. WolfA.J. VergnesL. OjciusD.M. RentsendorjA. VargasM. GuerreroC. WangY. FitzgeraldK.A. UnderhillD.M. TownT. ArditiM. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis.Immunity201236340141410.1016/j.immuni.2012.01.00922342844
     [Google Scholar]
  130. LinM. LiuN. QinZ. WangY. Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases.Acta Pharmacol. Sin.202243102439244710.1038/s41401‑022‑00879‑635233090
     [Google Scholar]
  131. IyerS.S. HeQ. JanczyJ.R. ElliottE.I. ZhongZ. OlivierA.K. SadlerJ.J. Knepper-AdrianV. HanR. QiaoL. EisenbarthS.C. NauseefW.M. CasselS.L. SutterwalaF.S. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation.Immunity201339231132310.1016/j.immuni.2013.08.00123954133
     [Google Scholar]
  132. WenceslauC.F. McCarthyC.G. GoulopoulouS. SzaszT. NeSmithE.G. WebbR.C. Mitochondrial-derived N-formyl peptides: Novel links between trauma, vascular collapse and sepsis.Med. Hypotheses201381453253510.1016/j.mehy.2013.06.02623890799
     [Google Scholar]
  133. DuvvuriB. BaddourA.A. DeaneK.D. FeserM.L. NelsonJ.L. DemoruelleM.K. LoodC. Mitochondrial N- formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis.J. Autoimmun.202111910263010.1016/j.jaut.2021.10263033713887
     [Google Scholar]
  134. SnezhkinaA.V. KudryavtsevaA.V. KardymonO.L. SavvateevaM.V. MelnikovaN.V. KrasnovG.S. DmitrievA.A. ROS generation and antioxidant defense systems in normal and malignant cells.Oxid. Med. Cell. Longev.2019201911710.1155/2019/617580431467634
     [Google Scholar]
  135. WestA.P. ShadelG.S. Mitochondrial DNA in innate immune responses and inflammatory pathology.Nat. Rev. Immunol.201717636337510.1038/nri.2017.2128393922
     [Google Scholar]
  136. JurewiczM.M. SternL.J. Class II MHC antigen processing in immune tolerance and inflammation.Immunogenetics201971317118710.1007/s00251‑018‑1095‑x30421030
     [Google Scholar]
  137. AlwehaidahM. AlsabbaghM. Al-kafajiG. Comprehensive analysis of mitochondrial DNA variants, mitochondrial DNA copy number and oxidative damage in psoriatic arthritis.Biomed. Rep.20231958510.3892/br.2023.166737881602
     [Google Scholar]
  138. ZhouD. ShaoL. SpitzD.R. Reactive oxygen species in normal and tumor stem cells.Adv. Cancer Res.201412216710.1016/B978‑0‑12‑420117‑0.00001‑324974178
     [Google Scholar]
  139. JingW. LiuC. SuC. LiuL. ChenP. LiX. ZhangX. YuanB. WangH. DuX. Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs.Front. Immunol.202314110767010.3389/fimmu.2023.110767036845127
     [Google Scholar]
  140. FlaquerA. BaumbachC. LadwigK-H. KriebelJ. WaldenbergerM. GrallertH. BaumertJ. MeitingerT. KruseJ. PetersA. EmenyR. StrauchK. Mitochondrial genetic variants identified to be associated with posttraumatic stress disorder.Transl. Psychiatry201553e52410.1038/tp.2015.1825756807
     [Google Scholar]
  141. PangaV. KallorA.A. NairA. HarshanS. RaghunathanS. Mitochondrial dysfunction in rheumatoid arthritis: A comprehensive analysis by integrating gene expression, protein-protein interactions and gene ontology data.PLoS One20191411e022463210.1371/journal.pone.022463231703070
     [Google Scholar]
  142. AndreuxP.A. HoutkooperR.H. AuwerxJ. Pharmacological approaches to restore mitochondrial function.Nat. Rev. Drug Discov.201312646548310.1038/nrd402323666487
     [Google Scholar]
  143. ChoiJ. PatelP. FenandoA. Sulfasalazine.StatPearlsTreasure Island, FLStatPearls Publishing2024
     [Google Scholar]
  144. ShamsS. MartinezJ.M. DawsonJ.R.D. FloresJ. GabrielM. GarciaG. GuevaraA. MurrayK. PacificiN. VargasM.V. VoelkerT. HellJ.W. AshouriJ.F. The therapeutic landscape of rheumatoid arthritis: Current state and future directions.Front. Pharmacol.20211268004310.3389/fphar.2021.68004334122106
     [Google Scholar]
  145. QinC. YangS. ChuY.H. ZhangH. PangX.W. ChenL. ZhouL.Q. ChenM. TianD.S. WangW. Signaling pathways involved in ischemic stroke: Molecular mechanisms and therapeutic interventions.Signal Transduct. Target. Ther.20227121510.1038/s41392‑022‑01064‑135794095
     [Google Scholar]
  146. LuoH. VongC.T. ChenH. GaoY. LyuP. QiuL. ZhaoM. LiuQ. ChengZ. ZouJ. YaoP. GaoC. WeiJ. UngC.O.L. WangS. ZhongZ. WangY. Naturally occurring anti-cancer compounds: Shining from Chinese herbal medicine.Chin. Med.20191414810.1186/s13020‑019‑0270‑931719837
     [Google Scholar]
  147. FangZ. ZhangM. LiuJ. ZhaoX. ZhangY. FangL. Tanshinone IIA: A Review of its anticancer effects.Front. Pharmacol.20211161108710.3389/fphar.2020.61108733597880
     [Google Scholar]
  148. YadavE. YadavP. KhanM.M.U. SinghH. VermaA. Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction.Front. Pharmacol.20221392223210.3389/fphar.2022.92223236188541
     [Google Scholar]
  149. ShaitoA. Al-MansoobM. AhmadS.M.S. HaiderM.Z. EidA.H. PosadinoA.M. PintusG. GiordoR. Resveratrol-mediated regulation of mitochondria biogenesis-associated pathways in neurodegenerative diseases: Molecular insights and potential therapeutic applications.Curr. Neuropharmacol.20232151184120110.2174/1570159X2066622101212285536237161
     [Google Scholar]
  150. FriedmanB. CronsteinB. Methotrexate mechanism in treatment of rheumatoid arthritis.Joint Bone Spine201986330130710.1016/j.jbspin.2018.07.00430081197
     [Google Scholar]
  151. WangG. PengX. A review of clinical applications and side effects of methotrexate in ophthalmology.J. Ophthalmol.2020202011110.1155/2020/153768932850138
     [Google Scholar]
  152. BhattacharyyaA. ChattopadhyayR. MitraS. CroweS.E. Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases.Physiol. Rev.201494232935410.1152/physrev.00040.201224692350
     [Google Scholar]
  153. KesarwaniP. MuraliA.K. Al-KhamiA.A. MehrotraS. Redox regulation of T-cell function: From molecular mechanisms to significance in human health and disease.Antioxid. Redox Signal.201318121497153410.1089/ars.2011.407322938635
     [Google Scholar]
  154. PaulM. HemshekharM. ThusharaR.M. SundaramM.S. NaveenKumarS.K. NaveenS. DevarajaS. SomyajitK. WestR. Basappa NayakaS.C. ZakaiU.I. NagarajuG. RangappaK.S. KemparajuK. GirishK.S. Methotrexate promotes platelet apoptosis via JNK-mediated mitochondrial damage: Alleviation by N-Acetylcysteine and N-acetylcysteine amide.PLoS One2015106e012755810.1371/journal.pone.012755826083398
     [Google Scholar]
  155. PaddaI.S. GoyalA. Leflunomide.StatPearls.Treasure Island, FLStatPearls Publishing2024
     [Google Scholar]
  156. DingM. ShiR. ChengS. LiM. DeD. LiuC. GuX. LiJ. ZhangS. JiaM. FanR. PeiJ. FuF. Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch.Redox Biol.20225210231110.1016/j.redox.2022.10231135413642
     [Google Scholar]
  157. GaoJ. ZhaoY. LiT. GanX. YuH. The role of PKM2 in the regulation of mitochondrial function: focus on mitochondrial metabolism, oxidative stress, dynamic, and apoptosis. PKM2 in mitochondrial function.Oxid. Med. Cell. Longev.202220221910.1155/2022/770268135571239
     [Google Scholar]
  158. CurtisJ.R. SinghJ.A. Use of biologics in rheumatoid arthritis: Current and emerging paradigms of care.Clin. Ther.201133667970710.1016/j.clinthera.2011.05.04421704234
     [Google Scholar]
  159. AltenR. Tocilizumab: A novel humanized anti-interleukin 6 receptor antibody for the treatment of patients with rheumatoid arthritis.Ther. Adv. Musculoskelet. Dis.20113313314910.1177/1759720X1140754022870473
     [Google Scholar]
  160. WarrenE. Gordon-LipkinE.M. CheungF. ChenJ. MukherjeeA. AppsR. TsangJ.S. JetmoreJ. KrukS. LeiY. WestA.P. McGuireP.J. Inflammatory and interferon gene expression signatures in patients with mitochondrial disease.Research square202310.21203/rs.3.rs‑2612547/v1
     [Google Scholar]
  161. PearceS.F. Rebelo-GuiomarP. D’SouzaA.R. PowellC.A. Van HauteL. MinczukM. Regulation of mammalian mitochondrial gene expression: Recent advances.Trends Biochem. Sci.201742862563910.1016/j.tibs.2017.02.00328285835
     [Google Scholar]
  162. BechmanK. YatesM. GallowayJ.B. The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors.Pharmacol. Res.201914710439210.1016/j.phrs.2019.10439231401212
     [Google Scholar]
  163. AngeliniJ. TalottaR. RoncatoR. FornasierG. BarbieroG. Dal CinL. BrancatiS. ScaglioneF. JAK-inhibitors for the treatment of rheumatoid arthritis: A focus on the present and an outlook on the future.Biomolecules2020107100210.3390/biom1007100232635659
     [Google Scholar]
  164. IvanovaI.G. PerkinsN.D. Hypoxia induces rapid, STAT3 and ROS dependent, mitochondrial translocation of RelA(p65) and IκBα.Biosci. Rep.2019399BSR2019210110.1042/BSR2019210131484794
     [Google Scholar]
  165. TangY.Y. WangD.C. WangY.Q. HuangA.F. XuW.D. Emerging role of hypoxia-inducible factor-1α in inflammatory autoimmune diseases: A comprehensive review.Front. Immunol.202313107397110.3389/fimmu.2022.107397136761171
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128354572250408165158
Loading
Connection Between Mitochondria and Rheumatoid Arthritis and Osteoarthritis: Personalized Treatment Strategies
Curr. Pharm. Des. 32, 651 (2026); https://doi.org/10.2174/0113816128354572250408165158
/content/journals/cpd/10.2174/0113816128354572250408165158
/content/journals/cpd/10.2174/0113816128354572250408165158
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): autoimmunity; immune response; inflammation; Osteoarthritis; rheumatic diseases; rheumatoid arthritis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test